32.sulphonamides Flashcards
how many groups does the classification of sulphonamides have?
4
1.oral absorbable agents
2.oral non-absorbable
3.topical
4.combined
which are the oral absorbable agents of sulphonamides
- short acting
-sulfisoxazole tab,500mg - medium
-sulfamethoxazole - long acting
-sulfadoxine
which are the oral non-absorbable agents of suphonamides
sulfaguanidine - tab.500mg
which are the topical agents of sulphonamides?
1.silver sulfadiazine - cream 1% 25g
2.sulfacetamide - collyr 10% 20ml
which are the combined drugs of sulphonamides?
1.co-trimoxazole (sulfamethoxazole + trimetroprim) - tab.120,480mg
2.fansidar (sulfadoxine + pyrimethamine) - tab.525mg
3.sulfasalazine - tab.entersolv.500mg
definition of sulphonamides
synthetic antimicrobial drugs, which are structural analogues of P-aminobenzoic acid
how are sulfonamides absorbed?
1.good oral absorption
2.exception is sulfaguanidine - used for GI infection
how are sulfonamides distributed?
1.through bodily fluids
2.penetrate well BBB and placental barrier
3.highly bound to plasma proteins - may displace other drugs from binding sites on serum albumin
how are sulfonamides metabolized + excretion ?
- in liver by acetylation
- metabolites precipitate at normal or acidic ph and form crystalluria
- urine excretion
Mechanism of action of non-combined sulfonamides
1.inhibit the synthesis of tetra—hydrofolic acid, which is synthesized from PABA
SA are structural analogs to PABA and compete with it for the bacterial enzyme dihydrofolate synthetase
2.have a bacteriostatic action
3.broad spectrum of action
-gram - : enterobacteriacae, not P.aeruginosa
-gram + : straphylo, strepto, actinomyces, nocardia
-protozoa: toxoplasma gondii
mechanism of action of combined SA
+ spectrum of action
1.cotrimoxazole inhibits 2 consequtive steps in formation of 4-hydrofolic acid
-sulfamethoxazole inhibits dihydrofolate synthetase
-trimethoprim inhibits dihydrofolate reductase
2.combined SA are bactericidal
adverse drug reactions of SA
1.disbacteriosis
2.hypersensitivity reaction: angioedema, steven johnson
3.nephrotoxicity due to crystalluria - prevent by adequate hydration
4.thrombocytopenia, granulocytopenia
5.hemolytic anemia in patients with G6PD deficiency
6.kernicterus in neonates - compete with bilirubin for its binding sites
drug interactions of Sulfonamides
- increased effect of warfarin - increased bleeding risk
- compete with antidiabetic drugs for their binding sites (sulfonylureas) - hypoglycemia risk
- alkalization increases their excretion
- local anesthetics with esther bond release PABA which decreases SA action